Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses

NCT01747616 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Syndrome

Interventions

DEVICE: Chitosan-N-acetylcysteine eye drops (concentration of 0.1%)
OTHER: Physiological saline solution

Sponsor

Medical University of Vienna

Collaborators

[object Object]